14-day Premium Trial Subscription Try For FreeTry Free
Extending yesterday's gain, NRx Pharmaceuticals Inc (NASDAQ: NRXP) stock is up more than 26% during the premarket trading on Friday. NRx's stock opened Thursday up nearly 14% at $11.51 per share aft
The stock price of NRX Pharmaceuticals Inc (NASDAQ: NRXP) increased by 42.86% after hours. This is why it happened.
NRXP stock came to investors' attention last year with its Covid-19 treatment. Now, it's looking like a great play as it eyes up EUA.
The stock price of NRx Pharmaceuticals Inc (NASDAQ: NRXP) increased by over 80% during intraday trading. This is why it happened.

Why NRx Pharmaceuticals Stock Is Soaring Today

12:04pm, Thursday, 22'nd Jul 2021
The company achieved two breakthroughs related to the formulation and manufacturing of Zyesami, its experimental COVID-19 drug.
RADNOR, Pa., July 22, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) announced today it has validated the first commercial formulation of ZYESAMI™ (aviptadil) for intravenous use, al
Shares of NRXP stock are taking off on Monday after the pharmaceutical company reported positive results regarding its Zyesami trial. The post NRXP Stock: The ‘Cykotine Storm' Drug News Sending NRx
The company reported promising data for its experimental COVID-19 drug Zyesami.
Penny Stocks & Small Caps Jump As Biotech Industry Names Kick Into High Gear The post Small-Cap Stocks To Watch After CYTK Sheds Spotlight On Biotech appeared first on Penny Stocks to Buy, Picks, News
The stock price of NRX Pharmaceuticals Inc (NASDAQ: NRXP) increased by over 30% during intraday trading. This is why it happened.
NRx Pharmaceuticals (NASDAQ: NRXP) identifies a statistically significant effect of Zyesami (aviptadil) in preventing the sharp rise in cytokines, commonly associated with mortality in patients with
RADNOR, Pa., July 19, 2021 /PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP), will present data at the Disease Control and Prevention Summit on July 21, 2021 at 10:10 EST, via the following link: ht
NRx Pharmaceuticals Inc (NASDAQ: NRXP) and Quantum Leap Healthcare Collaborative have begun treating patients with inhaled Zyesami (Aviptadil) in the I-SPY COVID Trial. The I-SPY COVID Trial utili
SAN FRANCISCO and RADNOR, Pa., July 12, 2021 /PRNewswire/ -- NRx Pharmaceuticals, Inc. ("NRx") (Nasdaq: NRXP) and Quantum Leap Healthcare Collaborative™ (Quantum Leap) have begun treating patients 
RADNOR, Pa., July 6, 2021 /PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP) (NRx), a clinical stage biopharmaceutical company, today announced it is initiating clinical training of Nation of Georgia
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE